Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Palbociclib in advanced cancer with cyclin pathway aberrations
NCT03123744Phase 2Withdrawn
- Start
- Jul 2018
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of palbociclib in cancer. Planned start Jul 2018; status: withdrawn.
02
Drugs
palbociclib
03
Conditions
cancer
Beyond the preview
Go deeper on NCT03123744.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03123744.